Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications-Reference-Cited by-同舟云学术

Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications

Published:2021-07 Issue:S1 Volume:43 Page:43-53
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematol

Author:

Soh Kah Teong¹,Wallace Paul K.¹^ORCID

Affiliation:

1. Department of Flow and Image Cytometry Roswell Park Comprehensive Cancer Center Buffalo NY USA

Funder

Division of Cancer Prevention, National Cancer Institute

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13562

Reference60 articles.

1. Cancer statistics, 2015

2. Cancer statistics, 2020

3. Multiple myeloma epidemiology and survival: A unique malignancy

4. Multiple Myeloma in Patients Younger Than 30 Years

5. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon Regulatory Factor 4: An Alternative Marker for Plasma Cells in Daratumumab‐Treated Patients With Multiple Myeloma;International Journal of Laboratory Hematology;2024-09-12

2. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index;Blood Cancer Journal;2023-12-01

3. La relación entre los parámetros inmunohistoquímicos, la fibrosis de la médula ósea y la captación de 18F-FDG en la médula ósea en pacientes con mieloma múltiple sometidos a examen PET/TC;Revista Española de Medicina Nuclear e Imagen Molecular;2023-09

4. The relationship between immunohistochemical parameters, bone marrow fibrosis and bone marrow 18F-FDG uptake in multiple myeloma patients undergoing PET/CT examination;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2023-09

5. Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs;Cancers;2023-03-30